AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
EVALUATION OF RU58841 AS AN ANTIANDROGEN IN PROSTATE PC3 CELLS AND A TOPICAL ANTI-ALOPECIA AGENT IN THE BALD SCALP OF STUMPTAILED MACAQUES
Authors: PAN HJ WILDING G UNO H INUI S GOLDSMITH L MESSING E CHANG CS
Citation: Hj. Pan et al., EVALUATION OF RU58841 AS AN ANTIANDROGEN IN PROSTATE PC3 CELLS AND A TOPICAL ANTI-ALOPECIA AGENT IN THE BALD SCALP OF STUMPTAILED MACAQUES, ENDOCRINE, 9(1), 1998, pp. 39-43
THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH RECOMBINANT HUMAN GAMMA-INTERFERON
Authors: SMALL EJ WEISS GR MALIK UK WALTHER PJ JOHNSON D WILDING G KUZEL T BEJAMONDE A PATON V
Citation: Ej. Small et al., THE TREATMENT OF METASTATIC RENAL-CELL CARCINOMA PATIENTS WITH RECOMBINANT HUMAN GAMMA-INTERFERON, The cancer journal from Scientific American, 4(3), 1998, pp. 162-167
RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN
Authors: HUTSON PR TUTSCH KD RAGO R ARZOOMANIAN R ALBERTI D POMPLUN M CHURCH D MARNOCHA R CHENG AL KEHRLI N WILDING G
Citation: Pr. Hutson et al., RENAL CLEARANCE, TISSUE DISTRIBUTION, AND CA-125 RESPONSES IN A PHASE-I TRIAL OF SURAMIN, Clinical cancer research, 4(6), 1998, pp. 1429-1436
PHASE-I CLINICAL-TRIAL OF PERILLYL ALCOHOL ADMINISTERED DAILY
Authors: RIPPLE GH GOULD MN STEWART JA TUTSCH KD ARZOOMANIAN RZ ALBERTI D FEIERABEND C POMPLUN M WILDING G BAILEY HH
Citation: Gh. Ripple et al., PHASE-I CLINICAL-TRIAL OF PERILLYL ALCOHOL ADMINISTERED DAILY, Clinical cancer research, 4(5), 1998, pp. 1159-1164
PHASE-I CLINICAL-TRIAL OF PERILLYL ALCOHOL ADMINISTERED DAILY
Authors: RIPPLE GH GOULD MN STEWART JA TUTSCH KD ARZOOMANIAN RZ ALBERTI D FEIERABEND C POMPLUN M WILDING G BAILEY HH
Citation: Gh. Ripple et al., PHASE-I CLINICAL-TRIAL OF PERILLYL ALCOHOL ADMINISTERED DAILY, Clinical cancer research, 4(5), 1998, pp. 1159-1164
A PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE (MMP) INHIBITOR, IN PATIENTS HAVING ADVANCED CANCER
Authors: HANDE K WILDING G RIPPLE G FRY J ARZOOMANIAN R DIXON M YUEN G COLLIER M
Citation: K. Hande et al., A PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE (MMP) INHIBITOR, IN PATIENTS HAVING ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 279-279
PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE INHIBITOR, IN COMBINATION WITH MITOXANTRONE PREDNISONE IN PATIENTS HAVING ADVANCED PROSTATE-CANCER/
Authors: WILDING G SMALL E RIPPLE G KELLER M YUEN G COLLIER M
Citation: G. Wilding et al., PHASE-I STUDY OF AG3340, A MATRIX METALLOPROTEASE INHIBITOR, IN COMBINATION WITH MITOXANTRONE PREDNISONE IN PATIENTS HAVING ADVANCED PROSTATE-CANCER/, Annals of oncology, 9, 1998, pp. 280-280
PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS
Authors: BAILEY H RIPPLE G GOULD M ARZOOMANIAN R ALBERTI D FEIERABEND C SIMON K MORGAN K TUTSCH K POMPLUN M WAHAMAKI A MARNOCHA R WILDING G
Citation: H. Bailey et al., PHASE-I TRIALS OF PERILLYL ALCOHOL ADMINISTERED ORALLY ON A CONTINUOUS DAILY BASIS, Annals of oncology, 9, 1998, pp. 409-409
PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF PENCLOMEDINE USING A NOVEL, 2-STAGE TRIAL DESIGN FOR PATIENTS WITH ADVANCED MALIGNANCY
Authors: BERLIN J STEWART JA STORER B TUTSCH KD ARZOOMANIAN RZ ALBERTI D FEIERABEND C SIMON K WILDING G
Citation: J. Berlin et al., PHASE-I CLINICAL AND PHARMACOKINETIC TRIAL OF PENCLOMEDINE USING A NOVEL, 2-STAGE TRIAL DESIGN FOR PATIENTS WITH ADVANCED MALIGNANCY, Journal of clinical oncology, 16(3), 1998, pp. 1142-1149
5-FLUOROURACIL AND LEUCOVORIN THERAPY IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-II STUDY (E1889)
Authors: BERLIN JD PROPERT KJ TRUMP D WILDING G HUDES G GLICK J BURCH P KELLER A LOEHRER P
Citation: Jd. Berlin et al., 5-FLUOROURACIL AND LEUCOVORIN THERAPY IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE-CANCER - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP PHASE-II STUDY (E1889), American journal of clinical oncology, 21(2), 1998, pp. 171-176
BILATERAL ORCHIECTOMY WITH OR WITHOUT FLUTAMIDE FOR METASTATIC PROSTATE-CANCER
Authors: EISENBERGER MA BLUMENSTEIN BA CRAWFORD ED MILLER G MCLEOD DG LOEHRER PJ WILDING G SEARS K CULKIN DJ THOMPSON IM BUESCHEN AJ LOWE BA
Citation: Ma. Eisenberger et al., BILATERAL ORCHIECTOMY WITH OR WITHOUT FLUTAMIDE FOR METASTATIC PROSTATE-CANCER, The New England journal of medicine, 339(15), 1998, pp. 1036-1042
PROMOTION OF AGONIST ACTIVITY OF ANTIANDROGENS BY THE ANDROGEN RECEPTOR COACTIVATOR, ARA70, IN HUMAN PROSTATE-CANCER DU145 CELLS
Authors: MIYAMOTO H YEH SY WILDING G CHANG CS
Citation: H. Miyamoto et al., PROMOTION OF AGONIST ACTIVITY OF ANTIANDROGENS BY THE ANDROGEN RECEPTOR COACTIVATOR, ARA70, IN HUMAN PROSTATE-CANCER DU145 CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(13), 1998, pp. 7379-7384
PHASE-I STUDY OF CONTINUOUS-INFUSION L-S,R-BUTHIONINE SULFOXIMINE WITH INTRAVENOUS MELPHALAN
Authors: BAILEY HH RIPPLE G TUTSCH KD ARZOOMANIAN RZ ALBERTI D FEIERABEND C MAHVI D SCHINK J POMPLUN M MULCAHY RT WILDING G
Citation: Hh. Bailey et al., PHASE-I STUDY OF CONTINUOUS-INFUSION L-S,R-BUTHIONINE SULFOXIMINE WITH INTRAVENOUS MELPHALAN, Journal of the National Cancer Institute, 89(23), 1997, pp. 1789-1796
PROOXIDANT-ANTIOXIDANT SHIFT INDUCED BY ANDROGEN TREATMENT OF HUMAN PROSTATE CARCINOMA-CELLS
Authors: RIPPLE MO HENRY WF RAGO RP WILDING G
Citation: Mo. Ripple et al., PROOXIDANT-ANTIOXIDANT SHIFT INDUCED BY ANDROGEN TREATMENT OF HUMAN PROSTATE CARCINOMA-CELLS, Journal of the National Cancer Institute, 89(1), 1997, pp. 40-48
QUANTITATION OF BETA-LAPACHONE AND 3-HYDROXY-BETA-LAPACHONE IN HUMAN PLASMA SAMPLES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
Authors: GLEN VL HUTSON PR KEHRLI NJ BOOTHMAN DA WILDING G
Citation: Vl. Glen et al., QUANTITATION OF BETA-LAPACHONE AND 3-HYDROXY-BETA-LAPACHONE IN HUMAN PLASMA SAMPLES BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 692(1), 1997, pp. 181-186
PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF ORAL CARBOXYAMIDOTRIAZOLE, A SIGNAL-TRANSDUCTION INHIBITOR
Authors: BERLIN J TUTSCH KD HUTSON P CLEARY J RAGO RP ARZOOMANIAN RZ ALBERTI D FEIERABEND C WILDING G
Citation: J. Berlin et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF ORAL CARBOXYAMIDOTRIAZOLE, A SIGNAL-TRANSDUCTION INHIBITOR, Journal of clinical oncology, 15(2), 1997, pp. 781-789
PHASE-I CLINICAL-TRIAL OF MELPHALAN AND 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN CANCER-PATIENTS
Authors: ROBINS HI RUSHING D KUTZ M TUTSCH KD TIGGELAAR CL PAUL D SPRIGGS D KRAEMER C GILLIS W FEIERABEND C ARZOOMANIAN RZ LONGO W ALBERTI D DOLEIRE F QU RP WILDING G STEWART JA
Citation: Hi. Robins et al., PHASE-I CLINICAL-TRIAL OF MELPHALAN AND 41.8-DEGREES-C WHOLE-BODY HYPERTHERMIA IN CANCER-PATIENTS, Journal of clinical oncology, 15(1), 1997, pp. 158-164
CONTINUOUS 28 DAY IODODEOXYURIDINE (IUDR) INFUSION AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR MALIGNANT GLIOMA - A PHASE-I CLINICAL AND THYMIDINE REPLACEMENT STUDY
Authors: SCHULZ CA MEHTA MP ROBINS HI BADIE B ARZOOMANIAN R SIMON K ALBERTI D FEIERABEND C KUNUGI KA WILDING G KINSELLA TJ
Citation: Ca. Schulz et al., CONTINUOUS 28 DAY IODODEOXYURIDINE (IUDR) INFUSION AND HYPERFRACTIONATED ACCELERATED RADIOTHERAPY (HART) FOR MALIGNANT GLIOMA - A PHASE-I CLINICAL AND THYMIDINE REPLACEMENT STUDY, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 139-139
EFFECTS OF THE POLYAMINE ANALOGS BE-4-4-4-4, BE-3-7-3, AND BE-3-3-3 ON THE PROLIFERATION OF 3 PROSTATE-CANCER CELL-LINES
Authors: JEFFERS L CHURCH D BASU H MARTON L WILDING G
Citation: L. Jeffers et al., EFFECTS OF THE POLYAMINE ANALOGS BE-4-4-4-4, BE-3-7-3, AND BE-3-3-3 ON THE PROLIFERATION OF 3 PROSTATE-CANCER CELL-LINES, Cancer chemotherapy and pharmacology, 40(2), 1997, pp. 172-179
A PHASE-I STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND LEVAMISOLE
Authors: CLEARY JF ARZOOMANIAN R ALBERTI D FEIERABEND C STORER B WITT P CARBONE P WILDING G
Citation: Jf. Cleary et al., A PHASE-I STUDY OF 5-FLUOROURACIL, LEUCOVORIN AND LEVAMISOLE, Cancer chemotherapy and pharmacology, 39(4), 1997, pp. 300-306
EXTENDED CULTURING OF ANDROGEN-RESPONSIVE HUMAN PRIMARY EPITHELIAL PROSTATE CELL ISOLATES BY CONTINUOUS TREATMENT WITH INTERSTITIAL COLLAGENASE
Authors: MITCHEN J OBERLEY T WILDING G
Citation: J. Mitchen et al., EXTENDED CULTURING OF ANDROGEN-RESPONSIVE HUMAN PRIMARY EPITHELIAL PROSTATE CELL ISOLATES BY CONTINUOUS TREATMENT WITH INTERSTITIAL COLLAGENASE, The Prostate, 30(1), 1997, pp. 7-19
PHASE-II TRIAL OF ORAL PIRITREXIM IN ADVANCED, PREVIOUSLY TREATED TRANSITIONAL-CELL CANCER OF BLADDER
Authors: KHORSAND M LANGE J FEUN L CLENDENINN NJ COLLIER M WILDING G
Citation: M. Khorsand et al., PHASE-II TRIAL OF ORAL PIRITREXIM IN ADVANCED, PREVIOUSLY TREATED TRANSITIONAL-CELL CANCER OF BLADDER, Investigational new drugs, 15(2), 1997, pp. 157-163
ALTERATION IN GAMMA-GLUTAMYL-TRANSPEPTIDASE ACTIVITY AND MESSENGER-RNA OF HUMAN PROSTATE CARCINOMA-CELLS BY ANDROGEN
Authors: RIPPLE MO PICKHARDT PA WILDING G
Citation: Mo. Ripple et al., ALTERATION IN GAMMA-GLUTAMYL-TRANSPEPTIDASE ACTIVITY AND MESSENGER-RNA OF HUMAN PROSTATE CARCINOMA-CELLS BY ANDROGEN, Cancer research, 57(12), 1997, pp. 2428-2433
A SENSITIVE TEST TO IDENTIFY EARLY METASTATIC LESIONS IN ADVANCED PROSTATE-CANCER
Authors: WU SQ HAFEZ R ZHANG JH NEWTON M WU HS WILDING G
Citation: Sq. Wu et al., A SENSITIVE TEST TO IDENTIFY EARLY METASTATIC LESIONS IN ADVANCED PROSTATE-CANCER, American journal of human genetics, 61(4), 1997, pp. 491-491
LEUCOVORIN MODULATION OF 5-IODODEOXYURIDINE RADIOSENSITIZATION - A PHASE-I STUDY
Authors: MCGINN CJ KUNUGI KA TUTSCH KD FEIERABEND C ALBERTI D LINDSTROM MJ WILDING G ARZOOMANIAN RZ KINSELLA TJ
Citation: Cj. Mcginn et al., LEUCOVORIN MODULATION OF 5-IODODEOXYURIDINE RADIOSENSITIZATION - A PHASE-I STUDY, Clinical cancer research, 2(8), 1996, pp. 1299-1305
Risultati: 1-25 | 26-39